 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | Thrombin ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dabigatran | +++ Thrombin, IC50: 9.3 nM | 98% | |||||||||||||||||
| Dabigatran etexilate | ✔ | 98% | |||||||||||||||||
| Argatroban | 99%+ | ||||||||||||||||||
| Heparin sodium salt | ✔ | ≥150 u/mg | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | Dabigatran, also known as BIBR 953, is an oral anticoagulant that acts as a reversible, potent, and competitive direct thrombin inhibitor with a Ki of 4.5 nM. It also inhibits thrombin-induced platelet aggregation with an IC50 of 10 nM[1][2]. In vitro, Dabigatran exhibits concentration-dependent anticoagulant effects across different species. At a concentration of 0.23 μM, it doubles the activated partial thromboplastin time (aPTT), prothrombin time (PT), and ecarin clotting time (ECT) in human platelet-poor plasma, with respective values of 0.83 and 0.18 μM[1]. | 
| Administration | Dosage | Frequency | Description | References | ||
| Neonatal rat pups | Germinal matrix hemorrhage model | Intraperitoneal and intranasal administration | 3 mg/kg, 10 mg/kg, 30 mg/kg | Twice daily for three days | Dabigatran improved long-term neurofunctional recovery and brain morphological outcomes, reduced intracranial pressure, and decreased expression of short-term p-mTOR and long-term extracellular matrix proteins. PAR-1 agonist co-administration partially reversed these effects. | J Cereb Blood Flow Metab. 2017 Sep;37(9):3135-3149 | 
| 细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 | 
| HEK293 cells | Function assay | 3 mins | Inhibition of human OCT2-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay, IC50=4.7 μM | 23241029 | 
| Animal study | Administered intravenously at doses ranging from 0.01 to 0.1 mg/kg, Dabigatran inhibits thrombus formation in the Wessler model, with an ED50 of 0.033 mg/kg[3]. | 
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 | 
| NCT02913326 | Thromboembolism | Phase 3 | Completed | - | - | 
| NCT02171598 | Healthy | Phase 1 | Completed | - | - | 
| NCT02240654 | - | Completed | - | - | |
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 2.12mL 0.42mL 0.21mL | 10.60mL 2.12mL 1.06mL | 21.21mL 4.24mL 2.12mL | |
| CAS号 | 211914-51-1 | 
| 分子式 | C25H25N7O3 | 
| 分子量 | 471.51 | 
| SMILES Code | O=C(O)CCN(C(C1=CC=C2C(N=C(CNC3=CC=C(C(N)=N)C=C3)N2C)=C1)=O)C4=NC=CC=C4 | 
| MDL No. | MFCD09837830 | 
| 别名 | BIBR 953; BIBR 953ZW | 
| 运输 | 蓝冰 | 
| InChI Key | YBSJFWOBGCMAKL-UHFFFAOYSA-N | 
| Pubchem ID | 216210 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, inert atmosphere, room temperature | 
| 溶解方案 | 0.1 M HCL: 10 mg/mL(21.21 mM),配合低频超声助溶 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1